CXO INSIGHTSTHREE C'S TO ENABLE CONTINUOUS DEVELOPMENT AND MANUFACTURING FOR SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT20Nick Thomson,Senior Director, Chemical Research and Development,Pfizer, Inc.SETTING A CULTURE FOR DIGITAL TRANSFORMATION IN THE BIOPHARMACEUTICAL INDUSTRY19Ross Kenyon,Associate Director ­ Modeling, Simulation and Analysis,Regeneron PharmaceuticalsLi Chen,Vice President & General Manager, Biologics,West Pharmaceutical Services, Inc.LEVERAGING TECHNOLOGY TO BOOST IMMUNOTHERAPY23Jessica Rayser,Associate Director of Product Management,Charles River LaboratoriesWHY STRAIN TYPING SHOULD BE IN YOUR MICROBIAL CONTROL TOOLBOX THE SECRET TO RESOLVING MICROBIAL CONTAMINATION INVESTIGATIONS: HOW PHARMA MANUFACTURERS CAN CONFIRM ROOT CAUSE28Paul R. Whitacre,PMP, Associate Director, Digital Excellence, Commercial Strategy & Operations Astellas Pharma US, Inc.THE WORLD OF OMNICHANNEL COMES TO LIFE SCIENCES: WHAT DIGITAL TRANSFORMATION LOOKS LIKE IN THE PHARMA INDUSTRY27Dean Erhardt,CEOD2 Solutions22J. Kelly Ganjei,CEOAmplifyBio18John W. Cropp,PhD, CEO and SVP of TechnologyEarly Access Care25FEATURED COMPANIES20 MOST PROMISINGPHARMA ANDLIFE SCIENCES TECH SOLUTIONS PROVIDERS - 2022John Jones ,Chief Executive OfficerEntitech Solutions26
< Page 4 | Page 6 >